Literature DB >> 12757700

A major step on the road to understanding a unique posttranslational modification and its role in a genetic disease.

Jacques U Baenziger1.   

Abstract

The posttranslational conversion of cysteine to C(alpha)-formylglycine in the catalytic site of mammalian sulfatases is deficient in the rare but devastating disorder multiple sulfatase deficiency (MSD). Two papers in this issue of Cell report the cloning of a gene responsible for this activity.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12757700     DOI： 10.1016/s0092-8674(03)00354-4

Source DB:  PubMed          Journal:  Cell        ISSN： 0092-8674            Impact factor:   41.582


  7 in total

Review 1.  The clinical significance of posttranslational modification of autoantigens.

Authors:  Maria G Zavala-Cerna; Erika A Martínez-García; Olivia Torres-Bugarín; Benjamín Rubio-Jurado; Carlos Riebeling; Arnulfo Nava
Journal:  Clin Rev Allergy Immunol       Date:  2014-08       Impact factor: 8.667

2.  Kaposi's sarcoma-associated herpesvirus K7 protein targets a ubiquitin-like/ubiquitin-associated domain-containing protein to promote protein degradation.

Authors:  Pinghui Feng; Christopher W Scott; Nam-Hyuk Cho; Hiroyuki Nakamura; Young-Hwa Chung; Mervyn J Monteiro; Jae U Jung
Journal:  Mol Cell Biol       Date:  2004-05       Impact factor: 4.272

3.  Overexpression of inactive arylsulphatase mutants and in vitro activation by light-dependent oxidation with vanadate.

Authors:  Terri M Christianson; Chris M Starr; Todd C Zankel
Journal:  Biochem J       Date:  2004-09-01       Impact factor: 3.857

4.  PEPPI: a peptidomic database of human protein isoforms for proteomics experiments.

Authors:  Ao Zhou; Fan Zhang; Jake Y Chen
Journal:  BMC Bioinformatics       Date:  2010-10-07       Impact factor: 3.169

5.  MODi: a powerful and convenient web server for identifying multiple post-translational peptide modifications from tandem mass spectra.

Authors:  Sangtae Kim; Seungjin Na; Ji Woong Sim; Heejin Park; Jaeho Jeong; Hokeun Kim; Younghwan Seo; Jawon Seo; Kong-Joo Lee; Eunok Paek
Journal:  Nucleic Acids Res       Date:  2006-07-01       Impact factor: 16.971

6.  EC5S ubiquitin complex is recruited by KSHV latent antigen LANA for degradation of the VHL and p53 tumor suppressors.

Authors:  Qi-Liang Cai; Jason S Knight; Suhbash C Verma; Philip Zald; Erle S Robertson
Journal:  PLoS Pathog       Date:  2006-10       Impact factor: 6.823

Review 7.  Development of idursulfase therapy for mucopolysaccharidosis type II (Hunter syndrome): the past, the present and the future.

Authors:  David Ah Whiteman; Alan Kimura
Journal:  Drug Des Devel Ther       Date:  2017-08-23       Impact factor: 4.162
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.